Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cavitation Technologies (CVAT) EBT (2016 - 2025)

Cavitation Technologies (CVAT) has disclosed EBT for 16 consecutive years, with -$476000.0 as the latest value for Q4 2025.

  • Quarterly EBT fell 58.14% to -$476000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.2 million through Dec 2025, down 773.6% year-over-year, with the annual reading at -$993000.0 for FY2025, 326.2% down from the prior year.
  • EBT hit -$476000.0 in Q4 2025 for Cavitation Technologies, down from -$258000.0 in the prior quarter.
  • In the past five years, EBT ranged from a high of $375000.0 in Q2 2024 to a low of -$1.4 million in Q2 2023.
  • Historically, EBT has averaged -$211300.0 across 5 years, with a median of -$236500.0 in 2023.
  • Biggest YoY gain for EBT was 239.08% in 2024; the steepest drop was 1781.25% in 2024.
  • Year by year, EBT stood at -$439000.0 in 2021, then skyrocketed by 34.4% to -$288000.0 in 2022, then soared by 94.44% to -$16000.0 in 2023, then tumbled by 1781.25% to -$301000.0 in 2024, then plummeted by 58.14% to -$476000.0 in 2025.
  • Business Quant data shows EBT for CVAT at -$476000.0 in Q4 2025, -$258000.0 in Q3 2025, and -$235000.0 in Q2 2025.